Piguet, V.; Blauvelt, A.; Burge, D.; Peterson, L.; Drew, J.; Rolleri, R.; Weglowska, J. Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT). J of Skin 2017, 1, s3.